|[September 27, 2013]
Research and Markets: Vital Signs - The Global Market for Type 2 Diabetes Therapeutics
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/8s8dkz/vital_signs_the)
has announced the addition of the "Vital
Signs - The Global Market for Type 2 Diabetes Therapeutics"
report to their offering.
This issue of Vital Signs provides a market overview and drug pipeline
analysis of Type 2 diabetes therapeutics. Additionally, a company
spotlight is provided for Trovagene in San Diego, CA (News - Alert). The company has a
proprietary transrenal nucleic acid platform with the potential to
deliver superior molecular diagnostics in urine.
The global revenue earned fom sales of drugs to treat type 2 diabetes
was approximately $36.89 billion in 2012. The rapidly growing incidence
and prevalence globally will help drive this figure to approximately
$68.42 billion by 2017. The market for type 2 diabetes therapeutics in
China is growing rapidly and is expected to outpace Europe to become the
second-largest market by 2017. South Korea and Vietnam are also forecast
to experience rapid growth.
The market for diabetes drugs has many barriers to entry, particularly
for the insulin segment, which requires a great deal of specialization.
Due to the chronic nature of the disease and the numerous co-morbidities
that make this patient population particularly sensitive to long-term
drug safety, the clinical and regulatory hurdles are considerable and
the inherent risks involved, such as failure to receive marketing
approval after a relatively large investment of time and money, limit
this market to those organizations with the necessary expertise and
capital. Despite the risk, the immense potential market has stimulated a
vast and growing pipeline of new therapies aimed at more precise glucose
control, improved safety profiles, and greater convenience to patients.
This article will summarize some of the key findings from a recent
analysis of the type 2 diabetes therapeutics market, which examines, in
detail, the insulin and non-insulin segments of this market on a global
For more information visit http://www.researchandmarkets.com/research/8s8dkz/vital_signs_the
[ Back To Technology News's Homepage ]